SLC6A3 and Parkinson disease: Moreover, we observed that in the brain of patients affected by PD, the DAT co-localized with phospho-α-synuclein (Figure 3E–G), which is considered a key neuropathological hallmark of LB in synucleinopathies [37,38,39].